These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 17400919)
21. Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Aertgeerts K; De Bondt HL; De Ranter CJ; Declerck PJ Nat Struct Biol; 1995 Oct; 2(10):891-7. PubMed ID: 7552714 [TBL] [Abstract][Full Text] [Related]
22. Reactive Center Loop Insertion in α-1-Antitrypsin Captured by Accelerated Molecular Dynamics Simulation. Andersen OJ; Risør MW; Poulsen EC; Nielsen NC; Miao Y; Enghild JJ; Schiøtt B Biochemistry; 2017 Jan; 56(4):634-646. PubMed ID: 27995800 [TBL] [Abstract][Full Text] [Related]
23. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility. Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229 [TBL] [Abstract][Full Text] [Related]
24. In vitro and in silico design of alpha1-antitrypsin mutants with different conformational stabilities. Gilis D; McLennan HR; Dehouck Y; Cabrita LD; Rooman M; Bottomley SP J Mol Biol; 2003 Jan; 325(3):581-9. PubMed ID: 12498804 [TBL] [Abstract][Full Text] [Related]
25. Different conformational changes within the F-helix occur during serpin folding, polymerization, and proteinase inhibition. Cabrita LD; Dai W; Bottomley SP Biochemistry; 2004 Aug; 43(30):9834-9. PubMed ID: 15274637 [TBL] [Abstract][Full Text] [Related]
26. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases. Wang Q; Shaltiel S BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892 [TBL] [Abstract][Full Text] [Related]
27. Analysis of serpin inhibitory function by mutagenesis of ovalbumin and generation of chimeric ovalbumin/PAI-2 fusion proteins. McCarthy BJ; Worrall DM J Mol Biol; 1997 Apr; 267(3):561-9. PubMed ID: 9126838 [TBL] [Abstract][Full Text] [Related]
28. The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted. Hägglöf P; Bergström F; Wilczynska M; Johansson LB; Ny T J Mol Biol; 2004 Jan; 335(3):823-32. PubMed ID: 14687577 [TBL] [Abstract][Full Text] [Related]
29. The 1.5 A crystal structure of a prokaryote serpin: controlling conformational change in a heated environment. Irving JA; Cabrita LD; Rossjohn J; Pike RN; Bottomley SP; Whisstock JC Structure; 2003 Apr; 11(4):387-97. PubMed ID: 12679017 [TBL] [Abstract][Full Text] [Related]
31. Suppression of the facile latency transition of alpha(1)-antitrypsin variant M(malton) by stabilizing mutations. Jung CH; Chae YK; Im H Biochem Biophys Res Commun; 2004 Dec; 325(3):744-50. PubMed ID: 15541353 [TBL] [Abstract][Full Text] [Related]
32. The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A. Ryu SE; Choi HJ; Kwon KS; Lee KN; Yu MH Structure; 1996 Oct; 4(10):1181-92. PubMed ID: 8939743 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a human alpha1-antitrypsin variant that is as stable as ovalbumin. Lee KN; Im H; Kang SW; Yu MH J Biol Chem; 1998 Jan; 273(5):2509-16. PubMed ID: 9446551 [TBL] [Abstract][Full Text] [Related]
34. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790 [TBL] [Abstract][Full Text] [Related]
36. Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F. Komissarov AA; Zhou A; Declerck PJ J Biol Chem; 2007 Sep; 282(36):26306-15. PubMed ID: 17613529 [TBL] [Abstract][Full Text] [Related]
37. The importance of helix F in plasminogen activator inhibitor-1. Vleugels N; Gils A; Bijnens AP; Knockaert I; Declerck PJ Biochim Biophys Acta; 2000 Jan; 1476(1):20-6. PubMed ID: 10606763 [TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility. De Taeye B; Gils A; Vleugels N; Rabijns A; Declerck PJ Biochem Biophys Res Commun; 2004 Aug; 321(3):746-51. PubMed ID: 15358169 [TBL] [Abstract][Full Text] [Related]
39. Protein conformational change delayed by steric hindrance from an N-linked glycan. Bager R; Johansen JS; Jensen JK; Stensballe A; Jendroszek A; Buxbom L; Sørensen HP; Andreasen PA J Mol Biol; 2013 Aug; 425(16):2867-77. PubMed ID: 23702291 [TBL] [Abstract][Full Text] [Related]
40. Structures of active and latent PAI-1: a possible stabilizing role for chloride ions. Stout TJ; Graham H; Buckley DI; Matthews DJ Biochemistry; 2000 Jul; 39(29):8460-9. PubMed ID: 10913251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]